Abundance of calpain and aggrecan-cleavage products of calpain in degenerated human intervertebral discs

Osteoarthritis and Cartilage

Volumn 19, Issue 10, 2011, Pages 1254-1262

  Fukuta, S ^a   Miyamoto, K ^a   Suzuki, K ^b   Maehara, H ^a   Inoue, T ^a   Kikuike, K ^a   Shimizu, K ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Division of Orthopedic Surgery   (Japan)

Author keywords

Aggrecanases; Calpain; Calpastatin; Disc degeneration; Human; Intervertebral disc

Indexed keywords

AGGRECAN; CALPAIN; CALPAIN 1; CALPASTATIN; META CALPAIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANNULUS FIBROSUS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; ENZYME LOCALIZATION; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC SCOLIOSIS; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK DEGENERATION; LUMBAR DISK HERNIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS PULPOSUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCHOOL CHILD; SPONDYLOLISTHESIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CALPAIN; CHILD; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; INTERVERTEBRAL DISC DEGENERATION; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SACRUM;

EID: 80052971460     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.07.010     Document Type: Article

References (50)

1. Luoma K., Riihimaki H., Luukkonen R., Raininko R., Viikari-Juntura E., Lamminen A. Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976) 2000, 25:487-492.
2. Rodriguez E., Roughley P. Link protein can retard the degradation of hyaluronan in proteoglycan aggregates. Osteoarthritis Cartilage 2006, 14:823-829.
3. Leung V.Y., Hung S.C., Li L.C., Wu E.X., Luk K.D., Chan D., et al. Age-related degeneration of lumbar intervertebral discs in rabbits revealed by deuterium oxide-assisted MRI. Osteoarthritis Cartilage 2008, 16:1312-1318.
4. Weiler C., Nerlich A.G., Zipperer J., Bachmeier B.E., Boos N. 2002 SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J 2002, 11:308-320.
5. Seguin C.A., Pilliar R.M., Roughley P.J., Kandel R.A. Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine (Phila Pa 1976) 2005, 30:1940-1948.
6. Le Maitre C.L., Freemont A.J., Hoyland J.A. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004, 204:47-54.
7. Le Maitre C.L., Freemont A.J., Hoyland J.A. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005, 7:R732-R745.
8. Miyamoto K., An H.S., Sah R.L., Akeda K., Okuma M., Otten L., et al. Exposure to pulsed low intensity ultrasound stimulates extracellular matrix metabolism of bovine intervertebral disc cells cultured in alginate beads. Spine (Phila Pa 1976) 2005, 30:2398-2405.
9. Patel K.P., Sandy J.D., Akeda K., Miyamoto K., Chujo T., An H.S., et al. Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration. Spine (Phila Pa 1976) 2007, 32:2596-2603.
10. Pockert A.J., Richardson S.M., Le Maitre C.L., Lyon M., Deakin J.A., Buttle D.J., et al. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum 2009, 60:482-491.
11. Roberts S., Caterson B., Menage J., Evans E.H., Jaffray D.C., Eisenstein S.M. Matrix metalloproteinases and aggrecanase: their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976) 2000, 25:3005-3013.
12. Sztrolovics R., Alini M., Roughley P.J., Mort J.S. Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 1997, 326(Pt 1):235-241.
13. Bachmeier B.E., Nerlich A., Mittermaier N., Weiler C., Lumenta C., Wuertz K., et al. Matrix metalloproteinase expression levels suggest distinct enzyme roles during lumbar disc herniation and degeneration. Eur Spine J 2009, 18:1573-1586.
14. Cole T.C., Ghosh P., Taylor T.K. Variations of the proteoglycans of the canine intervertebral disc with ageing. Biochim Biophys Acta 1986, 880:209-219.
15. Lyons G., Eisenstein S.M., Sweet M.B. Biochemical changes in intervertebral disc degeneration. Biochim Biophys Acta 1981, 673:443-453.
16. Roughley P.J., Alini M., Antoniou J. The role of proteoglycans in aging, degeneration and repair of the intervertebral disc. Biochem Soc Trans 2002, 30:869-874.
17. Oegema T.R. Biochemistry of the intervertebral disc. Clin Sports Med 1993, 12:419-439.
18. Miyamoto K., Masuda K., Kim J.G., Inoue N., Akeda K., Andersson G.B., et al. Intradiscal injections of osteogenic protein-1 restore the viscoelastic properties of degenerated intervertebral discs. Spine J 2006, 6:692-703.
19. Sorimachi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem J 1997, 328(Pt 3):721-732.
20. Goll D.E., Thompson V.F., Taylor R.G., Zalewska T. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin?. Bioessays 1992, 14:549-556.
21. Suzuki K., Tsuji S., Kubota S., Kimura Y., Imahori K. Limited autolysis of Ca2+-activated neutral protease (CANP) changes its sensitivity to Ca2+ ions. J Biochem 1981, 90:275-278.
22. Dayton W.R. Comparison of low- and high-calcium-requiring forms of the calcium-activated protease with their autocatalytic breakdown products. Biochim Biophys Acta 1982, 709:166-172.
23. Porn-Ares M.I., Samali A., Orrenius S. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ 1998, 5:1028-1033.
24. Suzuki K., Shimizu K., Hamamoto T., Nakagawa Y., Hamakubo T., Yamamuro T. Biochemical demonstration of calpains and calpastatin in osteoarthritic synovial fluid. Arthritis Rheum 1990, 33:728-732.
25. Maehara H., Suzuki K., Sasaki T., Oshita H., Wada E., Inoue T., et al. G1-G2 aggrecan product that can be generated by M-calpain on truncation at Ala709-Ala710 is present abundantly in human articular cartilage. J Biochem 2007, 141:469-477.
26. Lemke A.K., Sandy J.D., Voigt H., Dreier R., Lee J.H., Grodzinsky A.J., et al. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. Cell Tissue Res 2010, 340:179-188.
27. Suzuki K., Shimizu K., Hamamoto T., Nakagawa Y., Murachi T., Yamamuro T. Characterization of proteoglycan degradation by calpain. Biochem J 1992, 285(Pt 3):857-862.
28. Wakita S., Shimizu K., Suzuki K., Nakagawa Y., Yamamoto S., Yamamuro T. Chemonucleolysis with calpain I in rabbits. Spine (Phila Pa 1976) 1993, 18:159-164.
29. Tsuji T., Chiba K., Imabayashi H., Fujita Y., Hosogane N., Okada Y., et al. Age-related changes in expression of tissue inhibitor of metalloproteinases-3 associated with transition from the notochordal nucleus pulposus to the fibrocartilaginous nucleus pulposus in rabbit intervertebral disc. Spine (Phila Pa 1976) 2007, 32:849-856.
30. Thompson J.P., Pearce R.H., Schechter M.T., Adams M.E., Tsang I.K., Bishop P.B. Preliminary evaluation of a scheme for grading the gross morphology of the human intervertebral disc. Spine (Phila Pa 1976) 1990, 15:411-415.
31. Hascall V.C., Kimura J.H. Proteoglycans: isolation and characterization. Meth Enzymol 1982, 82(Pt A):769-800.
32. Farndale R.W., Sayers C.A., Barrett A.J. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982, 9:247-248.
33. Fosang A.J., Last K., Gardiner P., Jackson D.C., Brown L. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids. Biochem J 1995, 310(Pt 1):337-343.
34. Lane R.D., Allan D.M., Mellgren R.L. A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells. Exp Cell Res 1992, 203:5-16.
35. Doita M., Kanatani T., Ozaki T., Matsui N., Kurosaka M., Yoshiya S. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine (Phila Pa 1976) 2001, 26:1522-1527.
36. Shamji M.F., Betre H., Kraus V.B., Chen J., Chilkoti A., Pichika R., et al. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic. Arthritis Rheum 2007, 56:3650-3661.
37. Oshita H., Sandy J.D., Suzuki K., Akaike A., Bai Y., Sasaki T., et al. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain. Biochem J 2004, 382:253-259.
38. Yamamoto S., Shimizu K., Suzuki K., Nakagawa Y., Yamamuro T. Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum 1992, 35:1309-1317.
39. Struglics A., Hansson M. Calpain is involved in C-terminal truncation of human aggrecan. Biochem J 2010, 430:531-538.
40. Adams P., Muir H. Qualitative changes with age of proteoglycans of human lumbar discs. Ann Rheum Dis 1976, 35:289-296.
41. Goncalves I., Nitulescu M., Saido T.C., Dias N., Pedro L.M., José Fernandes E.F., et al. Activation of calpain-1 in human carotid artery atherosclerotic lesions. BMC Cardiovasc Disord 2009, 9:26.
42. Averna M., De Tullio R., Salamino F., Minafra R., Pontremoli S., Melloni E. Age-dependent degradation of calpastatin in kidney of hypertensive rats. J Biol Chem 2001, 276:38426-38432.
43. Averna M., Stifanese R., De Tullio R., Passalacqua M., Defranchi E., Salamino F., et al. Regulation of calpain activity in rat brain with altered Ca2+ homeostasis. J Biol Chem 2007, 282:2656-2665.
44. Hanna R.A., Campbell R.L., Davies P.L. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 2008, 456:U409-U478.
45. Paquet-Durand F., Azadi S., Hauck S.M., Ueffing M., van Veen T., Ekstrom P. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J Neurochem 2006, 96:802-814.
46. Rao M.V., Mohan P.S., Peterhoff C.M., Yang D.S., Schmidt S.D., Stavrides P.H., et al. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J Neurosci 2008, 28:12241-12254.
47. Walter H., Kawashima A., Nebelung W., Neumann W., Roessner A. Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol Res Pract 1998, 194:73-81.
48. Murphy G., Reynolds J.J., Werb Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem 1985, 260:3079-3083.
49. Seki S., Asanuma-Abe Y., Masuda K., Kawaguchi Y., Asanuma K., Muehleman C., et al. Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model. Arthritis Res Ther 2009, 11:R166.
50. Gruber H.E., Hanley E.N. Analysis of aging and degeneration of the human intervertebral disc. Comparison of surgical specimens with normal controls. Spine (Phila Pa 1976) 1998, 23:751-757.